STAA Q1 2025 Earnings — STAAR Surgical Company Revenue & Financial Results | Market Cap Arena

STAASTAAR Surgical Company

$860M

Q1 2025 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$43M-44.9% YoY

Gross Profit

$28M65.8% margin

Operating Income

-$57M-134.8% margin

Net Income

-$54M-127.3% margin

EPS (Diluted)

$-1.10

QoQ Revenue Growth

-13.0%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$7M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$457M

Total Liabilities

$107M

Stockholders' Equity

$350M

Cash & Equivalents

$173M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$43M	$77M	-44.9%
Gross Profit	$28M	$61M	-54.1%
Operating Income	-$57M	-$2M	-2416.5%
Net Income	-$54M	-$3M	-1523.6%

Revenue Segments

Implantable Collamer Lenses

$41M97%

Other Surgical Products

$1M3%